Literature DB >> 7607833

Long term outcome of renal transplantation in the pre cyclosporin era: one centre's experience.

P J Conlon1, W Medwar, S Hanson, J Donohoe, M Carmody, J J Walshe.   

Abstract

The number of renal transplants has been increasing steadily over the last twenty years. This increase has been associated with a significant improvement in the one year graft and patient survival. However, as survival improves, long term complications are becoming more clinically important. We, therefore, retrospectively reviewed our experience of renal transplantation in 165 patients between January 1970 and December 1980, and describe in detail the complications experienced by those whose grafts functioned for 10 years or longer. The 10 year patient survival rate was 47% and graft survival rate was 30%. The graft survival rate for living related grafts was superior to that of cadaveric grafts. The major cause of mortality in the first year following renal transplantation was infection and in subsequent years, cardiovascular disease predominated. Patients whose grafts functioned for 10 years or more developed a variety of complications including infection, skin cancer and hepatic dysfunction. Clinicians involved in the long term care of the patients need to be aware of these problems and skilled in their management.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607833     DOI: 10.1007/BF02973273

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  10 in total

1.  Causes of late renal allograft failure in the ciclosporin era.

Authors:  J H Hong; N Sumrani; V Delaney; R Davis; A Dibenedetto; K M Butt
Journal:  Nephron       Date:  1992       Impact factor: 2.847

2.  Lower prevalence of anti-hepatitis C antibody in dialysis and renal transplant patients in Ireland.

Authors:  P J Conlon; J J Walshe; E G Smyth; E B McNamara; J Donohoe; M Carmody
Journal:  Ir J Med Sci       Date:  1993-04       Impact factor: 1.568

3.  Advantages of low dose steroid from the day after renal transplantation.

Authors:  M G McGeown; J F Douglas; W A Brown; R A Donaldson; J A Kennedy; W G Loughridge; S Mehta; S D Nelson; C C Doherty; R Johnstone; G Todd; C M Hill
Journal:  Transplantation       Date:  1980-04       Impact factor: 4.939

4.  Risk factors for chronic rejection in renal allograft recipients.

Authors:  P S Almond; A Matas; K Gillingham; D L Dunn; W D Payne; P Gores; R Gruessner; J S Najarian
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

Review 5.  Tumors of the immunocompromised patient.

Authors:  I Penn
Journal:  Annu Rev Med       Date:  1988       Impact factor: 13.739

6.  Risk factors for accelerated atherosclerosis in renal transplant recipients.

Authors:  B L Kasiske
Journal:  Am J Med       Date:  1988-06       Impact factor: 4.965

7.  Late mortality and morbidity in recipients of long-term renal allografts.

Authors:  R L Kirkman; T B Strom; M R Weir; N L Tilney
Journal:  Transplantation       Date:  1982-12       Impact factor: 4.939

8.  Ten-year results of renal transplantation with azathioprine and prednisolone as only immunosuppression.

Authors:  M G McGeown; J F Douglas; R A Donaldson; C M Hill; J A Kennedy; W G Loughridge; D Middleton
Journal:  Lancet       Date:  1988-04-30       Impact factor: 79.321

9.  Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone.

Authors:  A H Wilkinson; J L Smith; L G Hunsicker; J Tobacman; D P Kapelanski; M Johnson; F H Wright; D M Behrendt; R J Corry
Journal:  Transplantation       Date:  1989-02       Impact factor: 4.939

10.  Acute graft rejection in the late survivors of renal transplantation. Clinical and histological observations in the second decade.

Authors:  K V Rao; B L Kasiske; P M Bloom
Journal:  Transplantation       Date:  1989-02       Impact factor: 4.939

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.